The presence of myelomonocytic specific markers, such as CD13, CD15, CD33, myeloperoxidase (MPO), CD14, and CD64 is useful for establishing the diagnosis of CD56‐positive acute myeloid leukemia, first presenting in the skin.11 This evidence concerns the gene MPO and acute myeloid leukemia.